Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03113578 · ClinicalTrials.gov registry record
Evaluation of the DiLumen Device During Colonoscopy
A clinical trial, sponsored by Lumendi.
- Completed
- Registry status
- 30
- Enrollment target
NCT03113578 is a clinical trial that has completed, run by Lumendi. The registered enrollment target is 30 participants.
The verdict
NCT03113578 has completed, sponsored by Lumendi.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This is an observational registry study collecting data on the clinical performance of the study device (DiLumen™ ) for its intended use. The primary objective is to evaluate functional outcomes of the DiLumen device in humans. The secondary objective is to evaluate safety characteristics of the DiLumen device.
Interventions
- DEVICE DiLumen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-04-26 |
| Est. Completion | 2017-09-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03113578
The ClinicalTrials.gov registry entry for NCT03113578 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lumendi, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DiLumen is the first listed.
NCT03113578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03113578 about?
NCT03113578 is a clinical study titled "Evaluation of the DiLumen Device During Colonoscopy". This is an observational registry study collecting data on the clinical performance of the study device (DiLumen™ ) for its intended use. The primary objective is to evaluate functional outcomes of the DiLumen device in humans. The secondary objective is to evaluate safety characteristics of the DiL...
What is the current status of trial NCT03113578?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2017-04-26. Estimated completion is 2017-09-27.
What interventions are being tested in trial NCT03113578?
The interventions under investigation include: DiLumen (DEVICE).
Who is sponsoring clinical trial NCT03113578?
This trial is sponsored by Lumendi, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.